Source: DGNews | Posted 8 years ago
Raptiva (Efalizumab) Promising as Long-Term Treatment for Moderate-to-Severe Plaque Psoriasis
Tags:
CHICAGO, IL -- July 29, 2003 -- Genentech, Inc. (NYSE: DNA) and XOMA Ltd. (Nasdaq: XOMA) announced positive results from two clinical studies evaluating the long-term safety and efficacy of treatment with Raptiva
Comments